Acute Care Volume 29, Issue 3

Medication Safety Alert! February 8, 2024

In this week's issue:

  • The Dark Side – Safety Issues When Protecting Medications from Light
  • Worth repeating… Respiratory Syncytial Virus (RSV) vaccines are not approved for children; AREXVY is not approved during pregnancy!
  • ECRI top 10 health technology hazards for 2024
  • Limit ketorolac therapy to 5 days
Related
All Featured Articles
Educational Services
Support ISMP
COVID-19 Resources
Featured article

The Dark Side—Safety Issues When Protecting Medications from Light

Read featured article

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)

Purchase a year's access to this bi-weekly publication for users at a single site location.